SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4ev4'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C6Z_B_ROCB505_1 (PROTEIN (PROTEASE))	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ASP A 131 GLY A 133 ALA A 134 ILE A 95 ILE A 113	None HAR A 100 ( 3.6A) None None None	1.03A	1c6zA-4ev4A: undetectable	1c6zA-4ev4A: 16.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 LYS A 234 GLY A 236	MER A 401 (-1.3A) MER A 401 ( 4.4A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.37A	1ghmA-4ev4A: 37.5	1ghmA-4ev4A: 31.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HSH_C_MK1C402_1 (HIV-II PROTEASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ALA A 48 ILE A 250 ILE A 285 ILE A 292 ILE A 259	None	0.93A	1hshC-4ev4A: undetectable	1hshC-4ev4A: 16.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I2W_A_CFXA1300_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	7 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 THR A 216 LYS A 234 GLY A 236	MER A 401 (-1.3A) MER A 401 ( 4.4A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.40A	1i2wA-4ev4A: 40.5	1i2wA-4ev4A: 45.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLY A 236 ARG A 220	MER A 401 (-1.3A) MER A 401 ( 4.4A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-3.6A) MER A 401 ( 3.9A)	1.19A	1i2wB-4ev4A: 40.8	1i2wB-4ev4A: 45.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 THR A 216 GLY A 236	MER A 401 (-1.3A) MER A 401 ( 4.4A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 ( 3.9A) MER A 401 (-3.6A)	0.43A	1i2wB-4ev4A: 40.8	1i2wB-4ev4A: 45.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SDT_B_MK1B902_2 (PROTEASE RETROPEPSIN)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ASP A 131 GLY A 133 ALA A 134 ILE A 95 ILE A 113	None HAR A 100 ( 3.6A) None None None	0.95A	1sdtB-4ev4A: undetectable	1sdtB-4ev4A: 17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SDU_B_MK1B902_2 (PROTEASE RETROPEPSIN)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ASP A 131 GLY A 133 ALA A 134 ILE A 95 ILE A 113	None HAR A 100 ( 3.6A) None None None	1.03A	1sduB-4ev4A: undetectable	1sduB-4ev4A: 17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T7I_A_017A200_1 (POL POLYPROTEIN)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 10	ASP A 131 GLY A 133 ALA A 134 ILE A 95 ILE A 113	None HAR A 100 ( 3.6A) None None None	1.02A	1t7iA-4ev4A: undetectable	1t7iA-4ev4A: 16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W0G_A_MYTA1499_1 (CYTOCHROME P450 3A4)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	4 / 6	ARG A 284 SER A 224 ILE A 221 THR A 265	None	0.96A	1w0gA-4ev4A: undetectable	1w0gA-4ev4A: 20.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YMX_A_CFXA1001_1 (BETA-LACTAMASE CTX-M-9)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	8 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 GLY A 236	MER A 401 (-1.3A) MER A 401 ( 4.4A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.56A	1ymxA-4ev4A: 42.4	1ymxA-4ev4A: 48.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YMX_B_CFXB1002_1 (BETA-LACTAMASE CTX-M-9)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	7 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	MER A 401 (-1.3A) MER A 401 ( 4.4A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.54A	1ymxB-4ev4A: 42.4	1ymxB-4ev4A: 48.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HS1_A_017A201_1 (HIV-1 PROTEASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ASP A 131 GLY A 133 ALA A 134 ILE A 95 ILE A 113	None HAR A 100 ( 3.6A) None None None	0.99A	2hs1A-4ev4A: undetectable	2hs1A-4ev4A: 16.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HS1_A_017A201_2 (HIV-1 PROTEASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ASP A 131 GLY A 133 ALA A 134 ILE A 95 ILE A 113	None HAR A 100 ( 3.6A) None None None	0.92A	2hs1B-4ev4A: undetectable	2hs1B-4ev4A: 16.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q64_B_1UNB1001_1 (PROTEASE RETROPEPSIN)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ASP A 131 GLY A 133 ALA A 134 ILE A 95 ILE A 113	None HAR A 100 ( 3.6A) None None None	0.97A	2q64A-4ev4A: undetectable	2q64A-4ev4A: 18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_D_ASDD1224_1 (GLUTATHIONE S-TRANSFERASE A3)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 9	PRO A 145 LEU A 162 LEU A 139 ALA A 135 PHE A 72	None	1.03A	2vcvD-4ev4A: undetectable	2vcvD-4ev4A: 23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_E_ASDE1224_1 (GLUTATHIONE S-TRANSFERASE A3)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 9	PRO A 145 LEU A 162 LEU A 139 ALA A 135 PHE A 72	None	1.00A	2vcvE-4ev4A: undetectable	2vcvE-4ev4A: 23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_H_ASDH1224_1 (GLUTATHIONE S-TRANSFERASE A3)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 9	PRO A 145 LEU A 162 LEU A 139 ALA A 135 PHE A 72	None	0.98A	2vcvH-4ev4A: undetectable	2vcvH-4ev4A: 23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_I_ASDI1224_1 (GLUTATHIONE S-TRANSFERASE A3)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 9	PRO A 145 LEU A 162 LEU A 139 ALA A 135 PHE A 72	None	1.05A	2vcvI-4ev4A: undetectable	2vcvI-4ev4A: 23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XPV_A_MIYA1209_1 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	SER A 289 ASN A 291 THR A 29 VAL A 28 GLN A 24	EDO A 402 (-2.5A) None EDO A 402 ( 4.7A) None None	1.47A	2xpvA-4ev4A: undetectable	2xpvA-4ev4A: 20.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CLB_B_TMQB612_1 (DHFR-TS)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ALA A 185 ASP A 157 MET A 152 PHE A 160 TYR A 264	EDO A 403 (-3.6A) EDO A 403 ( 4.2A) None None None	1.17A	3clbB-4ev4A: undetectable	3clbB-4ev4A: 19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D1Z_B_017B201_1 (HIV-1 PROTEASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ASP A 131 GLY A 133 ALA A 134 ILE A 95 ILE A 113	None HAR A 100 ( 3.6A) None None None	0.89A	3d1zA-4ev4A: undetectable	3d1zA-4ev4A: 17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKW_B_DR7B100_2 (PROTEASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ASP A 131 GLY A 133 ALA A 134 ILE A 95 ILE A 113	None HAR A 100 ( 3.6A) None None None	0.91A	3ekwB-4ev4A: undetectable	3ekwB-4ev4A: 16.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ELZ_B_CHDB151_0 (ILEAL BILE ACID-BINDING PROTEIN)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 10	ILE A 279 ILE A 221 GLY A 232 PHE A 211 VAL A 186	None	1.05A	3elzB-4ev4A: 1.1	3elzB-4ev4A: 20.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HLW_A_CE3A301_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	7 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 GLY A 236	MER A 401 ( 4.4A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.58A	3hlwA-4ev4A: 42.3	3hlwA-4ev4A: 48.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HLW_B_CE3B302_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	7 / 12	SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236	MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A)	0.50A	3hlwB-4ev4A: 42.4	3hlwB-4ev4A: 48.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HLW_B_CE3B302_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 130 ASN A 132 THR A 216 LYS A 234 THR A 235 GLY A 239	MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) None	0.82A	3hlwB-4ev4A: 42.4	3hlwB-4ev4A: 48.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HUO_A_PNNA300_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	LYS A 73 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	MER A 401 ( 4.4A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A)	0.47A	3huoA-4ev4A: 42.3	3huoA-4ev4A: 48.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HUO_B_PNNB301_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	LYS A 73 ASN A 132 ASN A 170 LYS A 234 GLY A 236	MER A 401 ( 4.4A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.46A	3huoB-4ev4A: 42.2	3huoB-4ev4A: 48.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 70 LYS A 73 ASN A 132 THR A 235 GLY A 236 ARG A 220	MER A 401 (-1.3A) MER A 401 ( 4.4A) MER A 401 (-3.2A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 ( 3.9A)	0.77A	3mzeA-4ev4A: 21.8	3mzeA-4ev4A: 23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NU3_B_478B401_1 (PROTEASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ASP A 131 GLY A 133 ALA A 134 ILE A 95 ILE A 113	None HAR A 100 ( 3.6A) None None None	0.93A	3nu3A-4ev4A: undetectable	3nu3A-4ev4A: 17.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3NY4_A_SMXA308_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.58A	3ny4A-4ev4A: 39.0	3ny4A-4ev4A: 43.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3Q07_A_WPPA300_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	MER A 401 ( 4.4A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.44A	3q07A-4ev4A: 42.2	3q07A-4ev4A: 48.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3Q07_B_WPPB400_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	MER A 401 ( 4.4A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.56A	3q07B-4ev4A: 39.4	3q07B-4ev4A: 48.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SH8_A_CEDA1_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 70 SER A 130 ASN A 132 LYS A 234 THR A 235 GLY A 236	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A)	0.48A	3sh8A-4ev4A: 39.6	3sh8A-4ev4A: 43.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 LYS A 234 GLY A 236	MER A 401 (-1.3A) MER A 401 ( 4.4A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.48A	3sh8B-4ev4A: 39.3	3sh8B-4ev4A: 43.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3T3C_A_017A201_1 (HIV-1 PROTEASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	4 / 7	ASP A 131 GLY A 133 ALA A 134 ILE A 113	None HAR A 100 ( 3.6A) None None	0.59A	3t3cA-4ev4A: undetectable	3t3cA-4ev4A: 16.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	11 / 12	LYS A 73 HIS A 105 SER A 130 ASN A 132 LEU A 167 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	MER A 401 ( 4.4A) MER A 401 ( 3.7A) MER A 401 (-2.8A) MER A 401 (-3.2A) None MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.57A	4euzA-4ev4A: 50.8	4euzA-4ev4A: 99.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 10	SER A 130 ASN A 132 LYS A 234 THR A 235 GLY A 236	MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A)	0.56A	4fh2A-4ev4A: 35.2	4fh2A-4ev4A: 37.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K87_A_ADNA602_1 (PROLINE--TRNA LIGASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	4 / 8	GLN A 112 GLY A 116 THR A 115 THR A 118	EDO A 404 ( 4.3A) None EDO A 404 (-4.0A) None	0.83A	4k87A-4ev4A: undetectable	4k87A-4ev4A: 21.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N9K_A_CEDA301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	7 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A)	0.40A	4n9kA-4ev4A: 41.1	4n9kA-4ev4A: 43.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	7 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A)	0.43A	4n9kB-4ev4A: 40.9	4n9kB-4ev4A: 43.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJV_D_RITD500_2 (PROTEASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ASP A 131 GLY A 133 ALA A 134 ILE A 95 ILE A 113	None HAR A 100 ( 3.6A) None None None	1.11A	4njvD-4ev4A: undetectable	4njvD-4ev4A: 15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O1Z_A_MXMA807_2 (PROSTAGLANDIN G/H SYNTHASE 1)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	4 / 6	LEU A 90 LEU A 138 PHE A 211 MET A 208	None	0.84A	4o1zA-4ev4A: undetectable	4o1zA-4ev4A: 18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OK1_A_198A1001_1 (ANDROGEN RECEPTOR)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	GLY A 74 LEU A 207 VAL A 249 ILE A 155 VAL A 198	None	1.06A	4ok1A-4ev4A: undetectable	4ok1A-4ev4A: 22.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	ASN A 132 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236	MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A)	0.46A	4pm5A-4ev4A: 42.1	4pm5A-4ev4A: 48.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A)	0.75A	4pm5A-4ev4A: 42.1	4pm5A-4ev4A: 48.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	LYS A 73 ASN A 132 ASN A 170 THR A 216 LYS A 234 GLY A 236	MER A 401 ( 4.4A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.58A	4pm7A-4ev4A: 42.0	4pm7A-4ev4A: 48.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	ASN A 132 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236	MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A)	0.47A	4pm9A-4ev4A: 41.9	4pm9A-4ev4A: 48.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A)	0.75A	4pm9A-4ev4A: 41.9	4pm9A-4ev4A: 48.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QD3_A_5AEA201_1 (PEPTIDYL-TRNA HYDROLASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 9	LEU A 33 GLY A 45 SER A 283 VAL A 286 LEU A 287	None	1.00A	4qd3A-4ev4A: undetectable	4qd3A-4ev4A: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2G_B_CTCB222_0 (TETRACYCLINE REPRESSOR PROTEIN CLASS D)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	SER A 289 ASN A 291 THR A 29 VAL A 28 GLN A 24	EDO A 402 (-2.5A) None EDO A 402 ( 4.7A) None None	1.43A	4v2gB-4ev4A: undetectable	4v2gB-4ev4A: 20.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZXI_A_GLYA1402_0 (TYROCIDINE SYNTHETASE 3)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	4 / 7	ASP A 246 ILE A 221 GLY A 232 THR A 235	None None None MER A 401 (-3.5A)	1.16A	4zxiA-4ev4A: undetectable	4zxiA-4ev4A: 12.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5A7M_A_ACTA1923_0 (BETA-XYLOSIDASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	3 / 3	ASP A 98 ARG A 96 TYR A 97	None	0.99A	5a7mA-4ev4A: undetectable	5a7mA-4ev4A: 17.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5A7M_B_ACTB1924_0 (BETA-XYLOSIDASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	3 / 3	ASP A 98 ARG A 96 TYR A 97	None	1.01A	5a7mB-4ev4A: undetectable	5a7mB-4ev4A: 17.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B8I_C_FK5C201_3 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	PHE A 195 VAL A 249 ILE A 250 PHE A 290 ILE A 292	None None None EDO A 402 ( 3.7A) None	1.21A	5b8iC-4ev4A: undetectable	5b8iC-4ev4A: 19.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GHY_A_CEDA301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.50A	5ghyA-4ev4A: 40.9	5ghyA-4ev4A: 43.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.48A	5ghyB-4ev4A: 40.9	5ghyB-4ev4A: 43.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GHZ_A_CEDA301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	7 / 11	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A)	0.47A	5ghzA-4ev4A: 40.9	5ghzA-4ev4A: 43.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GHZ_B_CEDB301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	7 / 10	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A)	0.47A	5ghzB-4ev4A: 41.0	5ghzB-4ev4A: 43.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LRB_A_ACRA1003_1 (ALPHA-1,4 GLUCAN PHOSPHORYLASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	4 / 6	PHE A 66 THR A 265 TYR A 264 PHE A 75	None	1.27A	5lrbA-4ev4A: undetectable	5lrbA-4ev4A: 15.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UXC_A_ZITA306_1 (PREDICTED AMINOGLYCOSIDE PHOSPHOTRANSFERASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	4 / 7	THR A 149 PHE A 72 ASP A 179 LEU A 169	None	1.14A	5uxcA-4ev4A: undetectable	5uxcA-4ev4A: 21.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YVN_A_ACTA305_0 (GLUTATHIONE S-TRANSFERASE OMEGA-1)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	4 / 6	LEU A 169 LYS A 73 LEU A 76 LEU A 139	None MER A 401 ( 4.4A) None None	1.08A	5yvnA-4ev4A: undetectable	5yvnA-4ev4A: 20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.41A	6b5yB-4ev4A: 39.5	6b5yB-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 130 THR A 216 ARG A 220 THR A 235 THR A 237 GLY A 239	MER A 401 (-2.8A) MER A 401 ( 3.9A) MER A 401 ( 3.9A) MER A 401 (-3.5A) MER A 401 (-3.7A) None	0.81A	6b5yB-4ev4A: 39.5	6b5yB-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	8 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.48A	6b5yD-4ev4A: 39.6	6b5yD-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	8 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.34A	6b68B-4ev4A: 39.6	6b68B-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	8 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 GLY A 236 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.42A	6b68D-4ev4A: 39.5	6b68D-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	8 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.32A	6b69A-4ev4A: 39.4 6b69B-4ev4A: 39.6	6b69A-4ev4A: 18.10 6b69B-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	7 / 12	SER A 70 SER A 130 PRO A 104 THR A 216 LYS A 234 THR A 235 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) None MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.7A)	1.34A	6b69A-4ev4A: 39.4 6b69B-4ev4A: 39.6	6b69A-4ev4A: 18.10 6b69B-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.33A	6b69D-4ev4A: 39.5	6b69D-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.37A	6b6aB-4ev4A: 39.4	6b6aB-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	8 / 12	SER A 70 SER A 130 ASN A 170 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.39A	6b6aD-4ev4A: 39.3	6b6aD-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	8 / 12	SER A 70 SER A 130 ASN A 170 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.48A	6b6cA-4ev4A: 39.2	6b6cA-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	7 / 12	SER A 70 SER A 130 PRO A 104 ARG A 220 LYS A 234 THR A 235 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) None MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.7A)	1.29A	6b6cA-4ev4A: 39.2	6b6cA-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	8 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.58A	6b6dA-4ev4A: 39.4	6b6dA-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.39A	6b6eA-4ev4A: 39.4	6b6eA-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	8 / 12	CSS A 69 SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 THR A 237	None MER A 401 (-1.3A) MER A 401 (-2.8A) MER A 401 (-2.9A) MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.6A) MER A 401 (-3.7A)	0.48A	6b6fA-4ev4A: 39.0	6b6fA-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 70 SER A 130 PRO A 104 LYS A 234 THR A 235 THR A 237	MER A 401 (-1.3A) MER A 401 (-2.8A) None MER A 401 (-3.0A) MER A 401 (-3.5A) MER A 401 (-3.7A)	1.43A	6b6fA-4ev4A: 39.0	6b6fA-4ev4A: 18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	6 / 12	SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 GLY A 236	MER A 401 (-2.8A) MER A 401 (-3.2A) MER A 401 (-2.9A) MER A 401 ( 3.9A) MER A 401 (-3.0A) MER A 401 (-3.6A)	0.45A	6c79A-4ev4A: 42.3	6c79A-4ev4A: 15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DH3_A_017A101_1 (PROTEASE)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	5 / 12	ASP A 131 GLY A 133 ALA A 134 ILE A 95 ILE A 113	None HAR A 100 ( 3.6A) None None None	0.96A	6dh3B-4ev4A: undetectable	6dh3B-4ev4A: 15.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWJ_B_GLYB710_0 (DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1)	4ev4	CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1 (Serratia fonticola)	4 / 5	ARG A 153 GLY A 156 ASN A 158 ASP A 157	None None EDO A 403 (-4.7A) EDO A 403 ( 4.2A)	1.37A	6dwjB-4ev4A: undetectable 6dwjD-4ev4A: undetectable	6dwjB-4ev4A: 20.19 6dwjD-4ev4A: 20.19

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C6Z_B_ROCB505_1","PROTEIN (PROTEASE);PROTEIN (PROTEASE)","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ASP A 131;GLY A 133;ALA A 134;ILE A  95;ILE A 113","None;HAR A 100 ( 3.6A);None;None;None","1.03A","1c6zA-4ev4A:undetectable","1c6zA-4ev4A:16.13"],["1GHM_A_CEDA1_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A  70;LYS A  73;SER A 130;ASN A 132;LYS A 234;GLY A 236","MER A 401 (-1.3A);MER A 401 ( 4.4A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.37A","1ghmA-4ev4A:37.5","1ghmA-4ev4A:31.60"],["1HSH_C_MK1C402_1","HIV-II PROTEASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ALA A  48;ILE A 250;ILE A 285;ILE A 292;ILE A 259","None","0.93A","1hshC-4ev4A:undetectable","1hshC-4ev4A:16.55"],["1I2W_A_CFXA1300_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",7,"SER A  70;LYS A  73;SER A 130;ASN A 132;THR A 216;LYS A 234;GLY A 236","MER A 401 (-1.3A);MER A 401 ( 4.4A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.40A","1i2wA-4ev4A:40.5","1i2wA-4ev4A:45.42"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLY A 236;ARG A 220","MER A 401 (-1.3A);MER A 401 ( 4.4A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-3.6A);MER A 401 ( 3.9A)","1.19A","1i2wB-4ev4A:40.8","1i2wB-4ev4A:45.42"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A  70;LYS A  73;SER A 130;ASN A 132;THR A 216;GLY A 236","MER A 401 (-1.3A);MER A 401 ( 4.4A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 ( 3.9A);MER A 401 (-3.6A)","0.43A","1i2wB-4ev4A:40.8","1i2wB-4ev4A:45.42"],["1SDT_B_MK1B902_2","PROTEASE RETROPEPSIN","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ASP A 131;GLY A 133;ALA A 134;ILE A  95;ILE A 113","None;HAR A 100 ( 3.6A);None;None;None","0.95A","1sdtB-4ev4A:undetectable","1sdtB-4ev4A:17.14"],["1SDU_B_MK1B902_2","PROTEASE RETROPEPSIN","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ASP A 131;GLY A 133;ALA A 134;ILE A  95;ILE A 113","None;HAR A 100 ( 3.6A);None;None;None","1.03A","1sduB-4ev4A:undetectable","1sduB-4ev4A:17.14"],["1T7I_A_017A200_1","POL POLYPROTEIN","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ASP A 131;GLY A 133;ALA A 134;ILE A  95;ILE A 113","None;HAR A 100 ( 3.6A);None;None;None","1.02A","1t7iA-4ev4A:undetectable","1t7iA-4ev4A:16.13"],["1W0G_A_MYTA1499_1","CYTOCHROME P450 3A4","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",4,"ARG A 284;SER A 224;ILE A 221;THR A 265","None","0.96A","1w0gA-4ev4A:undetectable","1w0gA-4ev4A:20.93"],["1YMX_A_CFXA1001_1","BETA-LACTAMASE CTX-M-9","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",8,"SER A  70;LYS A  73;SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;GLY A 236","MER A 401 (-1.3A);MER A 401 ( 4.4A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.56A","1ymxA-4ev4A:42.4","1ymxA-4ev4A:48.40"],["1YMX_B_CFXB1002_1","BETA-LACTAMASE CTX-M-9","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",7,"SER A  70;LYS A  73;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","MER A 401 (-1.3A);MER A 401 ( 4.4A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.54A","1ymxB-4ev4A:42.4","1ymxB-4ev4A:48.40"],["2HS1_A_017A201_1","HIV-1 PROTEASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ASP A 131;GLY A 133;ALA A 134;ILE A  95;ILE A 113","None;HAR A 100 ( 3.6A);None;None;None","0.99A","2hs1A-4ev4A:undetectable","2hs1A-4ev4A:16.49"],["2HS1_A_017A201_2","HIV-1 PROTEASE;HIV-1 PROTEASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ASP A 131;GLY A 133;ALA A 134;ILE A  95;ILE A 113","None;HAR A 100 ( 3.6A);None;None;None","0.92A","2hs1B-4ev4A:undetectable","2hs1B-4ev4A:16.49"],["2Q64_B_1UNB1001_1","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ASP A 131;GLY A 133;ALA A 134;ILE A  95;ILE A 113","None;HAR A 100 ( 3.6A);None;None;None","0.97A","2q64A-4ev4A:undetectable","2q64A-4ev4A:18.28"],["2VCV_D_ASDD1224_1","GLUTATHIONE S-TRANSFERASE A3","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"PRO A 145;LEU A 162;LEU A 139;ALA A 135;PHE A  72","None","1.03A","2vcvD-4ev4A:undetectable","2vcvD-4ev4A:23.23"],["2VCV_E_ASDE1224_1","GLUTATHIONE S-TRANSFERASE A3","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"PRO A 145;LEU A 162;LEU A 139;ALA A 135;PHE A  72","None","1.00A","2vcvE-4ev4A:undetectable","2vcvE-4ev4A:23.23"],["2VCV_H_ASDH1224_1","GLUTATHIONE S-TRANSFERASE A3","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"PRO A 145;LEU A 162;LEU A 139;ALA A 135;PHE A  72","None","0.98A","2vcvH-4ev4A:undetectable","2vcvH-4ev4A:23.23"],["2VCV_I_ASDI1224_1","GLUTATHIONE S-TRANSFERASE A3","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"PRO A 145;LEU A 162;LEU A 139;ALA A 135;PHE A  72","None","1.05A","2vcvI-4ev4A:undetectable","2vcvI-4ev4A:23.23"],["2XPV_A_MIYA1209_1","TETRACYCLINE REPRESSOR PROTEIN CLASS D","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"SER A 289;ASN A 291;THR A  29;VAL A  28;GLN A  24","EDO A 402 (-2.5A);None;EDO A 402 ( 4.7A);None;None","1.47A","2xpvA-4ev4A:undetectable","2xpvA-4ev4A:20.14"],["3CLB_B_TMQB612_1","DHFR-TS","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ALA A 185;ASP A 157;MET A 152;PHE A 160;TYR A 264","EDO A 403 (-3.6A);EDO A 403 ( 4.2A);None;None;None","1.17A","3clbB-4ev4A:undetectable","3clbB-4ev4A:19.35"],["3D1Z_B_017B201_1","HIV-1 PROTEASE;HIV-1 PROTEASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ASP A 131;GLY A 133;ALA A 134;ILE A  95;ILE A 113","None;HAR A 100 ( 3.6A);None;None;None","0.89A","3d1zA-4ev4A:undetectable","3d1zA-4ev4A:17.14"],["3EKW_B_DR7B100_2","PROTEASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ASP A 131;GLY A 133;ALA A 134;ILE A  95;ILE A 113","None;HAR A 100 ( 3.6A);None;None;None","0.91A","3ekwB-4ev4A:undetectable","3ekwB-4ev4A:16.13"],["3ELZ_B_CHDB151_0","ILEAL BILE ACID-BINDING PROTEIN","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ILE A 279;ILE A 221;GLY A 232;PHE A 211;VAL A 186","None","1.05A","3elzB-4ev4A:1.1","3elzB-4ev4A:20.43"],["3HLW_A_CE3A301_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",7,"LYS A  73;SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;GLY A 236","MER A 401 ( 4.4A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.58A","3hlwA-4ev4A:42.3","3hlwA-4ev4A:48.04"],["3HLW_B_CE3B302_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",7,"SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236","MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A)","0.50A","3hlwB-4ev4A:42.4","3hlwB-4ev4A:48.04"],["3HLW_B_CE3B302_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A 130;ASN A 132;THR A 216;LYS A 234;THR A 235;GLY A 239","MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);None","0.82A","3hlwB-4ev4A:42.4","3hlwB-4ev4A:48.04"],["3HUO_A_PNNA300_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"LYS A  73;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","MER A 401 ( 4.4A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A)","0.47A","3huoA-4ev4A:42.3","3huoA-4ev4A:48.04"],["3HUO_B_PNNB301_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"LYS A  73;ASN A 132;ASN A 170;LYS A 234;GLY A 236","MER A 401 ( 4.4A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.46A","3huoB-4ev4A:42.2","3huoB-4ev4A:48.04"],["3MZE_A_CFXA364_1","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A  70;LYS A  73;ASN A 132;THR A 235;GLY A 236;ARG A 220","MER A 401 (-1.3A);MER A 401 ( 4.4A);MER A 401 (-3.2A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 ( 3.9A)","0.77A","3mzeA-4ev4A:21.8","3mzeA-4ev4A:23.08"],["3NU3_B_478B401_1","PROTEASE;PROTEASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ASP A 131;GLY A 133;ALA A 134;ILE A  95;ILE A 113","None;HAR A 100 ( 3.6A);None;None;None","0.93A","3nu3A-4ev4A:undetectable","3nu3A-4ev4A:17.14"],["3NY4_A_SMXA308_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.58A","3ny4A-4ev4A:39.0","3ny4A-4ev4A:43.21"],["3Q07_A_WPPA300_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"LYS A  73;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","MER A 401 ( 4.4A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.44A","3q07A-4ev4A:42.2","3q07A-4ev4A:48.04"],["3Q07_B_WPPB400_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"LYS A  73;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","MER A 401 ( 4.4A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.56A","3q07B-4ev4A:39.4","3q07B-4ev4A:48.04"],["3SH8_A_CEDA1_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A  70;SER A 130;ASN A 132;LYS A 234;THR A 235;GLY A 236","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A)","0.48A","3sh8A-4ev4A:39.6","3sh8A-4ev4A:43.37"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A  70;LYS A  73;SER A 130;ASN A 132;LYS A 234;GLY A 236","MER A 401 (-1.3A);MER A 401 ( 4.4A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.48A","3sh8B-4ev4A:39.3","3sh8B-4ev4A:43.37"],["3T3C_A_017A201_1","HIV-1 PROTEASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",4,"ASP A 131;GLY A 133;ALA A 134;ILE A 113","None;HAR A 100 ( 3.6A);None;None","0.59A","3t3cA-4ev4A:undetectable","3t3cA-4ev4A:16.90"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",11,"LYS A  73;HIS A 105;SER A 130;ASN A 132;LEU A 167;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","MER A 401 ( 4.4A);MER A 401 ( 3.7A);MER A 401 (-2.8A);MER A 401 (-3.2A);None;MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.57A","4euzA-4ev4A:50.8","4euzA-4ev4A:99.29"],["4FH2_A_0RNA303_1","BETA-LACTAMASE SHV-1","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"SER A 130;ASN A 132;LYS A 234;THR A 235;GLY A 236","MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A)","0.56A","4fh2A-4ev4A:35.2","4fh2A-4ev4A:37.50"],["4K87_A_ADNA602_1","PROLINE--TRNA LIGASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",4,"GLN A 112;GLY A 116;THR A 115;THR A 118","EDO A 404 ( 4.3A);None;EDO A 404 (-4.0A);None","0.83A","4k87A-4ev4A:undetectable","4k87A-4ev4A:21.44"],["4N9K_A_CEDA301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",7,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A)","0.40A","4n9kA-4ev4A:41.1","4n9kA-4ev4A:43.37"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",7,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A)","0.43A","4n9kB-4ev4A:40.9","4n9kB-4ev4A:43.37"],["4NJV_D_RITD500_2","PROTEASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ASP A 131;GLY A 133;ALA A 134;ILE A  95;ILE A 113","None;HAR A 100 ( 3.6A);None;None;None","1.11A","4njvD-4ev4A:undetectable","4njvD-4ev4A:15.77"],["4O1Z_A_MXMA807_2","PROSTAGLANDIN G\/H SYNTHASE 1","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",4,"LEU A  90;LEU A 138;PHE A 211;MET A 208","None","0.84A","4o1zA-4ev4A:undetectable","4o1zA-4ev4A:18.90"],["4OK1_A_198A1001_1","ANDROGEN RECEPTOR","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"GLY A  74;LEU A 207;VAL A 249;ILE A 155;VAL A 198","None","1.06A","4ok1A-4ev4A:undetectable","4ok1A-4ev4A:22.07"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"ASN A 132;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236","MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A)","0.46A","4pm5A-4ev4A:42.1","4pm5A-4ev4A:48.40"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A)","0.75A","4pm5A-4ev4A:42.1","4pm5A-4ev4A:48.40"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"LYS A  73;ASN A 132;ASN A 170;THR A 216;LYS A 234;GLY A 236","MER A 401 ( 4.4A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.58A","4pm7A-4ev4A:42.0","4pm7A-4ev4A:48.40"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"ASN A 132;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236","MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A)","0.47A","4pm9A-4ev4A:41.9","4pm9A-4ev4A:48.06"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A)","0.75A","4pm9A-4ev4A:41.9","4pm9A-4ev4A:48.06"],["4QD3_A_5AEA201_1","PEPTIDYL-TRNA HYDROLASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"LEU A  33;GLY A  45;SER A 283;VAL A 286;LEU A 287","None","1.00A","4qd3A-4ev4A:undetectable","4qd3A-4ev4A:20.77"],["4V2G_B_CTCB222_0","TETRACYCLINE REPRESSOR PROTEIN CLASS D","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"SER A 289;ASN A 291;THR A  29;VAL A  28;GLN A  24","EDO A 402 (-2.5A);None;EDO A 402 ( 4.7A);None;None","1.43A","4v2gB-4ev4A:undetectable","4v2gB-4ev4A:20.14"],["4ZXI_A_GLYA1402_0","TYROCIDINE SYNTHETASE 3","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",4,"ASP A 246;ILE A 221;GLY A 232;THR A 235","None;None;None;MER A 401 (-3.5A)","1.16A","4zxiA-4ev4A:undetectable","4zxiA-4ev4A:12.56"],["5A7M_A_ACTA1923_0","BETA-XYLOSIDASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",3,"ASP A  98;ARG A  96;TYR A  97","None","0.99A","5a7mA-4ev4A:undetectable","5a7mA-4ev4A:17.00"],["5A7M_B_ACTB1924_0","BETA-XYLOSIDASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",3,"ASP A  98;ARG A  96;TYR A  97","None","1.01A","5a7mB-4ev4A:undetectable","5a7mB-4ev4A:17.00"],["5B8I_C_FK5C201_3","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"PHE A 195;VAL A 249;ILE A 250;PHE A 290;ILE A 292","None;None;None;EDO A 402 ( 3.7A);None","1.21A","5b8iC-4ev4A:undetectable","5b8iC-4ev4A:19.29"],["5GHY_A_CEDA301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.50A","5ghyA-4ev4A:40.9","5ghyA-4ev4A:43.37"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.48A","5ghyB-4ev4A:40.9","5ghyB-4ev4A:43.37"],["5GHZ_A_CEDA301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",7,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A)","0.47A","5ghzA-4ev4A:40.9","5ghzA-4ev4A:43.37"],["5GHZ_B_CEDB301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",7,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A)","0.47A","5ghzB-4ev4A:41.0","5ghzB-4ev4A:43.37"],["5LRB_A_ACRA1003_1","ALPHA-1,4 GLUCAN PHOSPHORYLASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",4,"PHE A  66;THR A 265;TYR A 264;PHE A  75","None","1.27A","5lrbA-4ev4A:undetectable","5lrbA-4ev4A:15.56"],["5UXC_A_ZITA306_1","PREDICTED AMINOGLYCOSIDE PHOSPHOTRANSFERASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",4,"THR A 149;PHE A  72;ASP A 179;LEU A 169","None","1.14A","5uxcA-4ev4A:undetectable","5uxcA-4ev4A:21.95"],["5YVN_A_ACTA305_0","GLUTATHIONE S-TRANSFERASE OMEGA-1","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",4,"LEU A 169;LYS A  73;LEU A  76;LEU A 139","None;MER A 401 ( 4.4A);None;None","1.08A","5yvnA-4ev4A:undetectable","5yvnA-4ev4A:20.62"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.41A","6b5yB-4ev4A:39.5","6b5yB-4ev4A:18.10"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A 130;THR A 216;ARG A 220;THR A 235;THR A 237;GLY A 239","MER A 401 (-2.8A);MER A 401 ( 3.9A);MER A 401 ( 3.9A);MER A 401 (-3.5A);MER A 401 (-3.7A);None","0.81A","6b5yB-4ev4A:39.5","6b5yB-4ev4A:18.10"],["6B5Y_D_9F2D400_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",8,"SER A  70;SER A 130;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.48A","6b5yD-4ev4A:39.6","6b5yD-4ev4A:18.10"],["6B68_B_9F2B301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",8,"SER A  70;SER A 130;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.34A","6b68B-4ev4A:39.6","6b68B-4ev4A:18.10"],["6B68_D_9F2D400_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",8,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;GLY A 236;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.42A","6b68D-4ev4A:39.5","6b68D-4ev4A:18.10"],["6B69_B_9F2B301_1","BETA-LACTAMASE;BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",8,"SER A  70;SER A 130;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.32A","6b69A-4ev4A:39.4;6b69B-4ev4A:39.6","6b69A-4ev4A:18.10;6b69B-4ev4A:18.10"],["6B69_B_9F2B301_1","BETA-LACTAMASE;BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",7,"SER A  70;SER A 130;PRO A 104;THR A 216;LYS A 234;THR A 235;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);None;MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.7A)","1.34A","6b69A-4ev4A:39.4;6b69B-4ev4A:39.6","6b69A-4ev4A:18.10;6b69B-4ev4A:18.10"],["6B69_D_9F2D301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.33A","6b69D-4ev4A:39.5","6b69D-4ev4A:18.10"],["6B6A_B_9F2B301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.37A","6b6aB-4ev4A:39.4","6b6aB-4ev4A:18.10"],["6B6A_D_9F2D301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",8,"SER A  70;SER A 130;ASN A 170;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.39A","6b6aD-4ev4A:39.3","6b6aD-4ev4A:18.10"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",8,"SER A  70;SER A 130;ASN A 170;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.48A","6b6cA-4ev4A:39.2","6b6cA-4ev4A:18.10"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",7,"SER A  70;SER A 130;PRO A 104;ARG A 220;LYS A 234;THR A 235;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);None;MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.7A)","1.29A","6b6cA-4ev4A:39.2","6b6cA-4ev4A:18.10"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",8,"SER A  70;SER A 130;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.58A","6b6dA-4ev4A:39.4","6b6dA-4ev4A:18.10"],["6B6E_A_9F2A302_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.39A","6b6eA-4ev4A:39.4","6b6eA-4ev4A:18.10"],["6B6F_A_9F2A301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",8,"CSS A  69;SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;THR A 237","None;MER A 401 (-1.3A);MER A 401 (-2.8A);MER A 401 (-2.9A);MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.6A);MER A 401 (-3.7A)","0.48A","6b6fA-4ev4A:39.0","6b6fA-4ev4A:18.10"],["6B6F_A_9F2A301_1","BETA-LACTAMASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A  70;SER A 130;PRO A 104;LYS A 234;THR A 235;THR A 237","MER A 401 (-1.3A);MER A 401 (-2.8A);None;MER A 401 (-3.0A);MER A 401 (-3.5A);MER A 401 (-3.7A)","1.43A","6b6fA-4ev4A:39.0","6b6fA-4ev4A:18.10"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",6,"SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;GLY A 236","MER A 401 (-2.8A);MER A 401 (-3.2A);MER A 401 (-2.9A);MER A 401 ( 3.9A);MER A 401 (-3.0A);MER A 401 (-3.6A)","0.45A","6c79A-4ev4A:42.3","6c79A-4ev4A:15.19"],["6DH3_A_017A101_1","PROTEASE","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",5,"ASP A 131;GLY A 133;ALA A 134;ILE A  95;ILE A 113","None;HAR A 100 ( 3.6A);None;None;None","0.96A","6dh3B-4ev4A:undetectable","6dh3B-4ev4A:15.48"],["6DWJ_B_GLYB710_0","DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1","4ev4","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","Serratia fonticola",4,"ARG A 153;GLY A 156;ASN A 158;ASP A 157","None;None;EDO A 403 (-4.7A);EDO A 403 ( 4.2A)","1.37A","6dwjB-4ev4A:undetectable;6dwjD-4ev4A:undetectable","6dwjB-4ev4A:20.19;6dwjD-4ev4A:20.19"]]